Weaker Opening
Stocks appeared set to open lower
Monday.
Gilead Sciences
(
GILD |
Quote |
Chart |
News |
PowerRating) reported
that the company received FDA approval for their Viread drug, which is used for
the treatment of HIV infection.
Dynacare
(
DNCR |
Quote |
Chart |
News |
PowerRating) has filed a
registration statement for a secondary offering of five million shares.
According to a report by the Wall
Street Journal Qualcomm
(
QCOM |
Quote |
Chart |
News |
PowerRating) is developing a satellite-based system
that will be capable of broadcasting live jetliner-cockpit conversations, flight
data and video of passenger activity inside the cabin. The technology will
utilize Globalstar Telecom’s
(
GSTRF |
Quote |
Chart |
News |
PowerRating) low-earth-satellite constellation.
Pharmaceutical company Biovail
(
BVF |
Quote |
Chart |
News |
PowerRating)
reported Q3 sales increased significantly and has entered into a number of
marketing agreements with GlaxoSmithKline.
Omincare
(
OCR |
Quote |
Chart |
News |
PowerRating) posted Q3 earnings
of 25 cents a share in line with analysts’ expectations according to a poll
taken by Thomson Financial/First CAll.
FedEx
(
FDX |
Quote |
Chart |
News |
PowerRating) raised its guidance
for the November quarter to come in between 40 cents – 45 cents, excluding any
government assistance. Analysts’ estimates were for 37 cents.
Merrill Lynch maintained its
Accumulate rating on UAL Corp
(
UAL |
Quote |
Chart |
News |
PowerRating) after the company’s chairman/CEO
resigned.
Lehman Brothers upgraded WorldCom
(
WCOM |
Quote |
Chart |
News |
PowerRating)
from Buy to Strong Buy.
Banc of America Securities downgraded
Exxon Mobil
(
XOM |
Quote |
Chart |
News |
PowerRating) from Strong Buy to Buy.
Merrill Lynch downgraded SEMCO Energy
(
SEN |
Quote |
Chart |
News |
PowerRating) from Long Term Neutral to Near Term Reduce.
King Pharmaceuticals
(
KG |
Quote |
Chart |
News |
PowerRating) posted Q2
earnings of 28 cents a share, beating analysts’ estimates by 2 cents.
Ariad Pharmaceuticals
(
ARIA |
Quote |
Chart |
News |
PowerRating)
announced that the company has discovered a number of highly potent anti-tumor
compounds.